A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

CAR T cell immunotherapy, which uses a patient's own modified immune cells to find and destroy cancer cells, can produce ...

I’ve lived with large granular lymphocytic leukemia for 16 years and have learned to spend my energy wisely, embrace ...